SEC Form 4 · Updated Daily
TVRD
— TVARDI THERAPEUTICS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Wirk Shaheen | Director | 263,164 | 2025-04-15 | J |
| HALL WALLACE L JR | Director | 202,044 | 2025-04-15 | J |
| Tweardy Samuel David | 10%+ Owner | 0 | 2025-07-07 | J |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-06-09 | WYZGA MICHAEL S | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | HALL WALLACE L JR | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Shah Sujal | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Smith Cynthia | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Shiff Susan Ph.D. | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-01-29 | Alibhai Imran Nizamudin | Grant / award (derivative) | 115,000 | $0.00 | 115,000 |
| 2026-01-29 | Kauh John Saewook M.D. | Grant / award (derivative) | 45,000 | $0.00 | 45,000 |
| 2026-01-29 | Conn Avi Daniel | Grant / award (derivative) | 45,000 | $0.00 | 45,000 |
| 2026-01-29 | O'Brien Stephen Paul | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-12-16 | Alibhai Imran Nizamudin | Grant / award (derivative) | 47,500 | $0.00 | 47,500 |
| 2025-12-16 | Conn Avi Daniel | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2025-12-16 | Kauh John Saewook M.D. | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2025-12-16 | O'Brien Stephen Paul | Grant / award (derivative) | 4,000 | $0.00 | 4,000 |
| 2025-07-07 | Tweardy Samuel David | J | 315,658 | $0.00 | 0 |
| 2025-04-17 | HALL WALLACE L JR | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Shah Sujal | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Smith Cynthia | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | WYZGA MICHAEL S | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Wirk Shaheen | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Shiff Susan Ph.D. | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Alibhai Imran Nizamudin | Grant / award (derivative) | 182,320 | $0.00 | 182,320 |
| 2025-04-17 | Kauh John Saewook M.D. | Grant / award (derivative) | 36,210 | $0.00 | 36,210 |
| 2025-04-17 | Conn Avi Daniel | Grant / award (derivative) | 43,547 | $0.00 | 43,547 |
| 2025-04-17 | Chen Yixin | Grant / award (derivative) | 7,213 | $0.00 | 7,213 |
| 2025-04-17 | O'Brien Stephen Paul | Grant / award (derivative) | 7,213 | $0.00 | 7,213 |
| 2025-04-17 | Larson Jeffrey Leroy | Grant / award (derivative) | 10,820 | $0.00 | 10,820 |
| 2025-04-15 | Larson Jeffrey Leroy | Grant / award (derivative) | 5,364 | — | 5,364 |
| 2025-04-15 | Larson Jeffrey Leroy | Grant / award (derivative) | 16,764 | — | 16,764 |
| 2025-04-15 | Shah Sujal | Grant / award (derivative) | 8,047 | — | 8,047 |
| 2025-04-15 | Shah Sujal | Grant / award (derivative) | 10,394 | — | 10,394 |
| 2025-04-15 | Wirk Shaheen | Grant / award (derivative) | 2,011 | — | 2,011 |
| 2025-04-15 | Wirk Shaheen | J | 263,164 | — | 263,164 |
| 2025-04-15 | Wirk Shaheen | J | 176,030 | — | 176,030 |
| 2025-04-15 | Wirk Shaheen | Grant / award | 4,191 | — | 4,191 |
| 2025-04-15 | Chen Yixin | Grant / award (derivative) | 14,752 | — | 14,752 |
| 2025-04-15 | WYZGA MICHAEL S | Grant / award (derivative) | 18,441 | — | 18,441 |
| 2025-04-15 | Kauh John Saewook M.D. | Grant / award (derivative) | 74,049 | — | 74,049 |
| 2025-04-15 | HALL WALLACE L JR | J | 202,044 | — | 202,044 |
| 2025-04-15 | HALL WALLACE L JR | J | 44,712 | — | 44,712 |
| 2025-04-15 | O'Brien Stephen Paul | Grant / award (derivative) | 3,352 | — | 3,352 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.